P3781
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic EsophagitisStudy to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaAbsolute Bioavailability of Reslizumab in Healthy SubjectsReslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab
P4844
description
Arzneimittel
@de
chemická sloučenina
@cs
chemische verbinding
@nl
component quimic
@oc
compost químic
@ca
composto chimico
@it
composto químico
@gl
composto químico
@pt
composto químico
@pt-br
composé chimique
@fr
name
Reslizumab
@de
Reslizumab
@en
Reslizumab
@vi
レスリズマブ
@ja
type
label
Reslizumab
@de
Reslizumab
@en
Reslizumab
@vi
レスリズマブ
@ja
altLabel
Cinqaero
@de
Cinqair
@en
DCP 835
@en
Sch 55700
@en
prefLabel
Reslizumab
@de
Reslizumab
@en
Reslizumab
@vi
レスリズマブ
@ja
P31
P486
P592
P6366
P2115
N0000192520
P2275
reslizumab
@en
P231
241473-69-8
P267
P3345
P3780
P486
P592
CHEMBL2107884
P6366
2779226105
P652
35A26E427H
P7830
Reslizumab